Physician profile
Monica Rani
NPI 1053552240
$8,024.42
in general payments reported to CMS, 2019-2025
18 companies · $6.76 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,544 · 2020: $65.04 · 2021: $108 · 2022: $37.43 · 2023: $119 · 2024: $144 · 2025: $6.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $255 · Education: $15.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $254.54 |
| Education | $15.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $6,909.03 | 2019-2024 | Dysport |
| Abbvie INC. | $389.59 | 2019-2024 | |
| Pfizer INC. | $210.64 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $99.99 | 2019 | |
| Novartis Pharmaceuticals Corporation | $97.59 | 2019-2023 | |
| Genzyme Corporation | $52.04 | 2020-2024 | |
| Ucb, INC. | $40.36 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $38.87 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $35.00 | 2024 | Libtayo |
| Medimetriks Pharmaceuticals, INC. | $25.42 | 2020-2021 | |
| Biofrontera INC. | $23.78 | 2021 | |
| Janssen Biotech, INC. | $19.26 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $18.58 | 2021 | |
| Amgen INC. | $15.37 | 2019 | |
| Celgene Corporation | $15.29 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermira, INC. | $13.66 | 2020 | |
| Lilly USA, LLC | $13.19 | 2023 | Taltz |
| Organon LLC | $6.76 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Rani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.